Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > More of the same

<< Previous

Bullboard Posts

Next >>

Comment by barsaxon Sep 15, 2022 1:35pm

122 Views

Post# 34964886

RE:RE:More of the same

"Someone from TD dumped $100,000 worth of stock "

That is 100% true. At 11:21 EDT someone dumped >$100,000USD worth of stock.

I have to say, though, since the beginning of the week it looks to me like someone is establishing a sizeable position in the stock. Its trading well, despite the constant chorus of complaints from the same cast of characters

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec